Preclinical Evaluation of A Potent 2nd Generation Small-Molecule Hsp90 Inhibitor STA-9090 In Hematological Cell Lines

被引:0
|
作者
Ying, Weiwen [1 ]
Proia, David [1 ]
He, Suqin [1 ]
Sang, Jim [1 ]
Foley, Kevin [1 ]
Du, Zhenjian [1 ]
Blackman, Ronald K. [1 ]
Wada, Yumiko [1 ]
Sun, Lijun [1 ]
Koya, Keizo [1 ]
机构
[1] Synta Pharmaceut, Lexington, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1194 / 1194
页数:1
相关论文
共 33 条
  • [1] STA-9090, a small-molecule Hsp90 inhibitor for the potential treatment of cancer
    Wang, Yisong
    Trepel, Jane B.
    Neckers, Leonard M.
    Giaccone, Giuseppe
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (12) : 1466 - 1476
  • [2] Synergy between the novel Hsp90 inhibitor STA-9090 and taxanes in preclinical models of NSCLC
    Foley, Kevin P.
    Proia, David
    Shimamura, Takeshi
    Borgman, Christa L.
    Inoue, Takayo
    Korbut, Tim
    Li, Danan
    Perera, Samanthi A.
    Sang, Jim
    Ogawa, Luisa Shin
    Smith, Don
    Tatsuta, Noriaki
    Ying, Weiwen
    Zhang, Chaohua
    Zhang, Haili
    Shapiro, Geoffrey I.
    Wong, Kwok-Kin
    Blackman, Ronald K.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : S234 - S234
  • [3] THE NEXT GENERATION HSP90 INHIBITOR STA-9090, CURRENTLY IN PHASE 2 TRIALS, DISPLAYS POTENT IN VITRO AND IN VIVO ACTIVITY
    Proia, D. A.
    Blackman, R. K.
    Foley, K. P.
    He, S.
    Kepros, J.
    Korbut, T.
    Sang, J.
    Smith, D.
    Ying, W.
    Zhang, C.
    Vukovic, V.
    Koya, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 35 - 35
  • [4] Potent anticancer actions of the Hsp90 inhibitor STA-9090 in wild-type EGFR models of lung cancer
    Acquaviva, Jaime
    Sang, Jim
    Sequeira, Manuel
    Smith, Donald
    Zhang, Chaohua
    Lovly, Christine
    Wada, Yumiko
    Blackman, Ronald K.
    Proia, David A.
    CANCER RESEARCH, 2011, 71
  • [5] A Phase I Study of the Potent Hsp90 Inhibitor STA-9090 Administered Twice Weekly In Subjects with Hematologic Malignancies
    Padmanabhan, Swaminathan
    Kelly, Kevin R.
    Heaney, Mark
    Hodges, Stephanie
    Chanel, Suzanne
    Frattini, Mark
    Swords, Ronan
    Bradley, Robert
    Teofilovici, Florentina
    DeAngelo, Daniel J.
    BLOOD, 2010, 116 (21) : 1193 - 1193
  • [6] The novel Hsp90 inhibitor STA-9090 has potent anticancer activity in in vitro and in vivo models of lung cancer
    Shimamura, Takeshi
    Borgman, Christa
    Chen, Liang
    Li, Danan
    Foley, Kevin
    Sang, Jim
    Meyerson, Matthew
    Ying, Weiwen
    Barsoum, James
    Wong, Kwok-Kin
    Shapiro, Geoffrey
    CANCER RESEARCH, 2009, 69
  • [7] Investigation of anticancer activities of STA-9090 (ganetespib) as a second generation HSP90 inhibitor in Saos-2 osteosarcoma cells
    Ozgur, Aykut
    JOURNAL OF CHEMOTHERAPY, 2021, 33 (08) : 554 - 563
  • [8] Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non-Small Cell Lung Cancer
    Shimamura, Takeshi
    Perera, Samanthi A.
    Foley, Kevin P.
    Sang, Jim
    Rodig, Scott J.
    Inoue, Takayo
    Chen, Liang
    Li, Danan
    Carretero, Julian
    Li, Yu-Chen
    Sinha, Papiya
    Carey, Christopher D.
    Borgman, Christa L.
    Jimenez, John-Paul
    Meyerson, Matthew
    Ying, Weiwen
    Barsoum, James
    Wong, Kwok-Kin
    Shapiro, Geoffrey I.
    CLINICAL CANCER RESEARCH, 2012, 18 (18) : 4973 - 4985
  • [9] A Phase II Study Of The Hsp90 Inhibitor STA-9090 Administered To Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
    Goldman, J.
    Paschold, E. H.
    Webb, T.
    Chen, L.
    Kozcywas, M.
    Lufkin, J. M.
    Vukovic, V.
    Shapiro, G. I.
    Socinski, M. A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S560 - S560
  • [10] Phase I evaluation of STA-1474, a pro-drug of the novel HSP90 inhibitor STA-9090, in dogs with spontaneous cancer
    London, Cheryl A.
    Bear, Misty D.
    McCleese, Jennifer
    Foley, Kevin P.
    Paalangara, Reji
    Inoue, Takayo
    Ying, Weiwen
    Barsoum, James
    CANCER RESEARCH, 2011, 71